User menu

New and Emerging Therapies and Targets: Beta-3 Agonists.

Bibliographic reference Michel, Lauriane ; Balligand, Jean-Luc. New and Emerging Therapies and Targets: Beta-3 Agonists.. In: Handbook of Experimental Pharmacology, (2016)
Permanent URL http://hdl.handle.net/2078.1/180978
  1. Ahmet I., Beneficial Effects of Chronic Pharmacological Manipulation of  -Adrenoreceptor Subtype Signaling in Rodent Dilated Ischemic Cardiomyopathy, 10.1161/01.cir.0000139844.15045.f9
  2. Amour Julien, Loyer Xavier, Le Guen Morgan, Mabrouk Nejma, David Jean-St??phane, Camors Emmanuel, Carusio Nunzia, Vivien Beno??t, Andriantsitohaina Ramaroson, Heymes Christophe, Riou Bruno, Altered Contractile Response due to Increased ??3-Adrenoceptor Stimulation in Diabetic Cardiomyopathy : The Role of Nitric Oxide Synthase 1???derived Nitric Oxide, 10.1097/01.anes.0000278909.40408.24
  3. Angelone T., Filice E., Quintieri A. M., Imbrogno S., Recchia A., Pulerà E., Mannarino C., Pellegrino D., Cerra M. C., β3-Adrenoceptors modulate left ventricular relaxation in the rat heart via the NO-cGMP-PKG pathway, 10.1111/j.1748-1716.2008.01838.x
  4. Aragón Juan P., Condit Marah E., Bhushan Shashi, Predmore Benjamin L., Patel Sandeep S., Grinsfelder D. Bennett, Gundewar Susheel, Jha Saurabh, Calvert John W., Barouch Lili A., Lavu Madhav, Wright Harold M., Lefer David J., Beta3-Adrenoreceptor Stimulation Ameliorates Myocardial Ischemia-Reperfusion Injury Via Endothelial Nitric Oxide Synthase and Neuronal Nitric Oxide Synthase Activation, 10.1016/j.jacc.2011.09.033
  5. Ayers K., Byrne L. M., DeMatteo A., Brown N. J., Differential Effects of Nebivolol and Metoprolol on Insulin Sensitivity and Plasminogen Activator Inhibitor in the Metabolic Syndrome, 10.1161/hypertensionaha.111.189589
  6. Belge C., Hammond J., Dubois-Deruy E., Manoury B., Hamelet J., Beauloye C., Markl A., Pouleur A.-C., Bertrand L., Esfahani H., Jnaoui K., Gotz K. R., Nikolaev V. O., Vanderper A., Herijgers P., Lobysheva I., Iaccarino G., Hilfiker-Kleiner D., Tavernier G., Langin D., Dessy C., Balligand J.-L., Enhanced Expression of  3-Adrenoceptors in Cardiac Myocytes Attenuates Neurohormone-Induced Hypertrophic Remodeling Through Nitric Oxide Synthase, 10.1161/circulationaha.113.004940
  7. Bristow M. R.,  -Adrenergic Receptor Blockade in Chronic Heart Failure, 10.1161/01.cir.101.5.558
  8. Bristow Michael R., Ginsburg Robert, Minobe Wayne, Cubicciotti Roger S., Sageman W. Scott, Lurie Keith, Billingham Margaret E., Harrison Donald C., Stinson Edward B., Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts, 10.1056/nejm198207223070401
  9. Bristow M. R., The surgically denervated, transplanted human heart, 10.1161/01.cir.82.2.658
  10. Brodde OE (1991) Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43:203–242
  11. Brodde Otto-Erich, Beta-adrenoceptors in cardiac disease, 10.1016/0163-7258(93)90030-h
  12. Bundgaard H., Liu C.-C., Garcia A., Hamilton E. J., Huang Y., Chia K. K. M., Hunyor S. N., Figtree G. A., Rasmussen H. H.,  3 Adrenergic Stimulation of the Cardiac Na+-K+ Pump by Reversal of an Inhibitory Oxidative Modification, 10.1161/circulationaha.110.964619
  13. Calvert J. W., Condit M. E., Aragon J. P., Nicholson C. K., Moody B. F., Hood R. L., Sindler A. L., Gundewar S., Seals D. R., Barouch L. A., Lefer D. J., Exercise Protects Against Myocardial Ischemia-Reperfusion Injury via Stimulation of  3-Adrenergic Receptors and Increased Nitric Oxide Signaling: Role of Nitrite and Nitrosothiols, 10.1161/circresaha.111.241117
  14. Candelore M R, Deng L, Tota L M, Kelly L J, Cascieri M A, Strader C D, Pharmacological characterization of a recently described human beta 3-adrenergic receptor mutant., 10.1210/endo.137.6.8641219
  15. Cheng H.-J., Zhang Z.-S., Onishi K., Ukai T., Sane D. C., Cheng C.-P., Upregulation of Functional  3-Adrenergic Receptor in the Failing Canine Myocardium, 10.1161/hh1901.098042
  16. Chesley A., Lundberg M. S., Asai T., Xiao R.-P., Ohtani S., Lakatta E. G., Crow M. T., The  2-Adrenergic Receptor Delivers an Antiapoptotic Signal to Cardiac Myocytes Through Gi-Dependent Coupling to Phosphatidylinositol 3'-Kinase, 10.1161/01.res.87.12.1172
  17. Chruscinski Andrzej J., Rohrer Daniel K., Schauble Eric, Desai Kavin H., Bernstein Daniel, Kobilka Brian K., Targeted Disruption of the β2 Adrenergic Receptor Gene, 10.1074/jbc.274.24.16694
  18. Chu Guoxiang, Lester James W., Young Karen B., Luo Wusheng, Zhai Jing, Kranias Evangelia G., A Single Site (Ser16) Phosphorylation in Phospholamban Is Sufficient in Mediating Its Maximal Cardiac Responses to β-Agonists, 10.1074/jbc.m004079200
  19. Cypess Aaron M., Lehman Sanaz, Williams Gethin, Tal Ilan, Rodman Dean, Goldfine Allison B., Kuo Frank C., Palmer Edwin L., Tseng Yu-Hua, Doria Alessandro, Kolodny Gerald M., Kahn C. Ronald, Identification and Importance of Brown Adipose Tissue in Adult Humans, 10.1056/nejmoa0810780
  20. Cypess Aaron M., Weiner Lauren S., Roberts-Toler Carla, Elía Elisa Franquet, Kessler Skyler H., Kahn Peter A., English Jeffrey, Chatman Kelly, Trauger Sunia A., Doria Alessandro, Kolodny Gerald M., Activation of Human Brown Adipose Tissue by a β3-Adrenergic Receptor Agonist, 10.1016/j.cmet.2014.12.009
  21. Lefkowitz Robert J., Daaka Yehia, Luttrell Louis M., 10.1038/36362
  22. Danielsen Wiebke, der Leyen Heiko v., Meyer Wilfried, Neumann Joachim, Schmitz Wilhelm, Scholz Hasso, Starbatty Jutta, Stein Birgitt, Döring Volker, Kalmár Peter, Basal and Isoprenaline-Stimulated cAMP Content in Failing Versus Nonfailing Human Cardiac Preparations : , 10.1097/00005344-198907000-00026
  23. Dash R., Kadambi V. J., Schmidt A. G., Tepe N. M., Biniakiewicz D., Gerst M. J., Canning A. M., Abraham W. T., Hoit B. D., Liggett S. B., Lorenz J. N., Dorn G. W., Kranias E. G., Interactions Between Phospholamban and  -Adrenergic Drive May Lead to Cardiomyopathy and Early Mortality, 10.1161/01.cir.103.6.889
  24. de Luis D.A., Aller R., Izaola O., Gonzalez Sagrado M., Conde R., Relation of Trp64Arg Polymorphism of Beta 3-Adrenergic Receptor Gene to Adipocytokines and Fat Distribution in Obese Patients, 10.1159/000144047
  25. Dessy Chantal, Balligand Jean-Luc, Beta3-Adrenergic Receptors in Cardiac and Vascular Tissues, Cardiovascular Pharmacology - Heart and Circulation (2010) ISBN:9780123849038 p.135-163, 10.1016/s1054-3589(10)59005-7
  26. Dessy C., Endothelial  3-Adrenoceptors Mediate Vasorelaxation of Human Coronary Microarteries Through Nitric Oxide and Endothelium-Dependent Hyperpolarization, 10.1161/01.cir.0000139331.85766.af
  27. Dessy C., Endothelial  3-Adrenoreceptors Mediate Nitric Oxide-Dependent Vasorelaxation of Coronary Microvessels in Response to the Third-Generation  -Blocker Nebivolol, 10.1161/circulationaha.104.532960
  28. Dincer U. D., Bidasee K. R., Guner S., Tay A., Ozcelikay A. T., Altan V. M., The Effect of Diabetes on Expression of  1-,  2-, and  3-Adrenoreceptors in Rat Hearts, 10.2337/diabetes.50.2.455
  29. Donckier J. E., Massart P.-E., Van Mechelen H., Heyndrickx G. R., Gauthier C., Balligand J.-L., Cardiovascular effects of beta 3-adrenoceptor stimulation in perinephritic hypertension, 10.1046/j.1365-2362.2001.00872.x
  30. Dumas Monique, Dumas Jean-Paul, Bardou Marc, Rochette Luc, Advenier Charles, Giudicelli Jean-François, Influence of β-adrenoceptor agonists on the pulmonary circulation. Effects of a β3-adrenoceptor antagonist, SR 59230A, 10.1016/s0014-2999(98)00146-0
  31. Edwards Gillian, Félétou Michel, Weston Arthur H., Endothelium-derived hyperpolarising factors and associated pathways: a synopsis, 10.1007/s00424-010-0817-1
  32. Emorine L., Marullo S, Briend-Sutren M., Patey G, Tate K, Delavier-Klutchko C, Strosberg A., Molecular characterization of the human beta 3-adrenergic receptor, 10.1126/science.2570461
  33. Engelhardt Stefan, Böhm Michael, Erdmann Erland, Lohse Martin J., Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: Progressive reduction of beta1-adrenergic receptor mRNA in heart failure, 10.1016/0735-1097(95)00425-4
  34. Eschenhagen T, G proteins and the heart, 10.1006/cbir.1993.1135
  35. Fatima Tahzeeb, Altaf Sara, Phipps-Green Amanda, Topless Ruth, Flynn Tanya J., Stamp Lisa K., Dalbeth Nicola, Merriman Tony R., Association analysis of the beta-3 adrenergic receptor Trp64Arg (rs4994) polymorphism with urate and gout, 10.1007/s00296-015-3370-6
  36. Feldman M D, Alderman J D, Aroesty J M, Royal H D, Ferguson J J, Owen R M, Grossman W, McKay R G, Depression of systolic and diastolic myocardial reserve during atrial pacing tachycardia in patients with dilated cardiomyopathy., 10.1172/jci113778
  37. García-Prieto Jaime, García-Ruiz Jose Manuel, Sanz-Rosa David, Pun Andrés, García-Alvarez Ana, Davidson Sean M., Fernández-Friera Leticia, Nuno-Ayala Mario, Fernández-Jiménez Rodrigo, Bernal Juan A., Izquierdo-Garcia José Luis, Jimenez-Borreguero Jesús, Pizarro Gonzalo, Ruiz-Cabello Jesús, Macaya Carlos, Fuster Valentín, Yellon Derek M., Ibanez Borja, β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes, 10.1007/s00395-014-0422-0
  38. Gauthier C, Tavernier G, Charpentier F, Langin D, Le Marec H, Functional beta3-adrenoceptor in the human heart., 10.1172/jci118823
  39. Gauthier C, Leblais V, Kobzik L, Trochu J N, Khandoudi N, Bril A, Balligand J L, Le Marec H, The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle., 10.1172/jci2191
  40. Gauthier C, Tavernier G, Trochu JN, Leblais V, Laurent K, Langin D, Escande D, Le Marec H (1999) Interspecies differences in the cardiac negative inotropic effects of beta(3)-adrenoceptor agonists. J Pharmacol Exp Ther 290:687–693
  41. Gauthier Chantal, Langin Dominique, Balligand Jean-Luc, β3-Adrenoceptors in the cardiovascular system, 10.1016/s0165-6147(00)01562-5
  42. He J.-Q., Crosstalk of  -Adrenergic Receptor Subtypes Through Gi Blunts  -Adrenergic Stimulation of L-Type Ca2+ Channels in Canine Heart Failure, 10.1161/01.res.0000181160.31851.05
  43. Hoffmann C., Leitz M. R., Oberdorf-Maass S., Lohse M. J., Klotz K.-N., Comparative pharmacology of human �-adrenergic receptor subtypes?characterization of stably transfected receptors in CHO cells, 10.1007/s00210-003-0860-y
  44. Idigo Winifred O., Reilly Svetlana, Zhang Mei Hua, Zhang Yin Hua, Jayaram Raja, Carnicer Ricardo, Crabtree Mark J., Balligand Jean-Luc, Casadei Barbara, Regulation of Endothelial Nitric-oxide Synthase (NOS)S-Glutathionylation by Neuronal NOS : EVIDENCE OF A FUNCTIONAL INTERACTION BETWEEN MYOCARDIAL CONSTITUTIVE NOS ISOFORMS, 10.1074/jbc.m112.412031
  45. Imbrogno S., Gattuso A., Mazza R., Angelone T., Cerra M. C., β3-AR and the vertebrate heart: a comparative view, 10.1111/apha.12493
  46. Ishikawa Y, Sorota S, Kiuchi K, Shannon R P, Komamura K, Katsushika S, Vatner D E, Vatner S F, Homcy C J, Downregulation of adenylylcyclase types V and VI mRNA levels in pacing-induced heart failure in dogs., 10.1172/jci117219
  47. Karimi Galougahi Keyvan, Liu Chia-Chi, Garcia Alvaro, Fry Natasha A., Hamilton Elisha J., Figtree Gemma A., Rasmussen Helge H., β3-Adrenoceptor activation relieves oxidative inhibition of the cardiac Na+-K+pump in hyperglycemia induced by insulin receptor blockade, 10.1152/ajpcell.00071.2015
  48. Kiuchi K, Shannon R P, Komamura K, Cohen D J, Bianchi C, Homcy C J, Vatner S F, Vatner D E, Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure., 10.1172/jci116312
  49. Komajda M., Lam C. S. P., Heart failure with preserved ejection fraction: a clinical dilemma, 10.1093/eurheartj/ehu067
  50. Kou Ruqin, Michel Thomas, Epinephrine Regulation of the Endothelial Nitric-oxide Synthase : ROLES OF RAC1 AND β3-ADRENERGIC RECEPTORS IN ENDOTHELIAL NO SIGNALING, 10.1074/jbc.m706815200
  51. Kruger M., Kotter S., Grutzner A., Lang P., Andresen C., Redfield M. M., Butt E., dos Remedios C. G., Linke W. A., Protein Kinase G Modulates Human Myocardial Passive Stiffness by Phosphorylation of the Titin Springs, 10.1161/circresaha.108.184408
  52. Lefkowitz R. J., Haber E., O'Hara D., Identification of the Cardiac Beta-Adrenergic Receptor Protein: Solubilization and Purification by Affinity Chromatography, 10.1073/pnas.69.10.2828
  53. Liggett S. B., Freedman N. J., Schwinn D. A., Lefkowitz R. J., Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor., 10.1073/pnas.90.8.3665
  54. Lim Shir Lynn, Lam Carolyn S.P., Segers Vincent F.M., Brutsaert Dirk L., De Keulenaer Gilles W., Cardiac endothelium–myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction, 10.1093/eurheartj/ehv132
  55. Lobysheva Irina I., Biller Pauline, Gallez Bernard, Beauloye Christophe, Balligand Jean-Luc, Nitrosylated Hemoglobin Levels in Human Venous Erythrocytes Correlate with Vascular Endothelial Function Measured by Digital Reactive Hyperemia, 10.1371/journal.pone.0076457
  56. Longabaugh J P, Vatner D E, Vatner S F, Homcy C J, Decreased stimulatory guanosine triphosphate binding protein in dogs with pressure-overload left ventricular failure., 10.1172/jci113335
  57. Longhurst J. C., Coronary arteriolar vasoconstriction in myocardial ischaemia: reflexes, sympathetic nervous system, catecholamines, 10.1093/eurheartj/11.suppl_b.43
  58. Mahata Sushil K, Zheng Hong, Mahata Sumana, Liu Xuefei, Patel Kaushik P, Effect of heart failure on catecholamine granule morphology and storage in chromaffin cells, 10.1530/joe-16-0146
  59. Maier Lars S, A Novel Mechanism for the Treatment of Angina, Arrhythmias, and Diastolic Dysfunction: Inhibition of Late INa Using Ranolazine : , 10.1097/fjc.0b013e3181a1b9e7
  60. Malik Safarina G, Saraswati Made R, Suastika Ketut, Trimarsanto Hidayat, Oktavianthi Sukma, Sudoyo Herawati, Association of beta3-adrenergic receptor (ADRB3) Trp64Arg gene polymorphism with obesity and metabolic syndrome in the Balinese: a pilot study, 10.1186/1756-0500-4-167
  61. Manning CD, McLaughlin MM, Livi GP, Cieslinski LB, Torphy TJ, Barnette MS (1996) Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B. J Pharmacol Exp Ther 276:810–818
  62. Massion P. B., Cardiomyocyte-Restricted Overexpression of Endothelial Nitric Oxide Synthase (NOS3) Attenuates  -Adrenergic Stimulation and Reinforces Vagal Inhibition of Cardiac Contraction, 10.1161/01.cir.0000145608.80855.bc
  63. Moniotte S., Kobzik L., Feron O., Trochu J.-N., Gauthier C., Balligand J.-L., Upregulation of  3-Adrenoceptors and Altered Contractile Response to Inotropic Amines in Human Failing Myocardium, 10.1161/01.cir.103.12.1649
  64. Moniotte S., Vaerman J.L., Kockx M.M., Larrouy D., Langin D., Noirhomme P., Balligand J.L., Real-time RT-PCR for the Detection of Beta-adrenoceptor Messenger RNAs in Small Human Endomyocardial Biopsies, 10.1006/jmcc.2001.1475
  65. Nantel F, Bonin H, Emorine LJ, Zilberfarb V, Strosberg AD, Bouvier M, Marullo S (1993) The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization. Mol Pharmacol 43:548–555
  66. Nedergaard Jan, Cannon Barbara, The Browning of White Adipose Tissue: Some Burning Issues, 10.1016/j.cmet.2014.07.005
  67. Neumann Joachim, Scholz Hasso, Döring Volker, Schmitz Wilhelm, Meyerinck LutzVon, Kalmár Peter, INCREASE IN MYOCARDIAL Gi-PROTEINS IN HEART FAILURE, 10.1016/s0140-6736(88)92601-3
  68. Niu Xiaolin, Watts Vabren L., Cingolani Oscar H., Sivakumaran Vidhya, Leyton-Mange Jordan S., Ellis Carla L., Miller Karen L., Vandegaer Konrad, Bedja Djahida, Gabrielson Kathleen L., Paolocci Nazareno, Kass David A., Barouch Lili A., Cardioprotective Effect of Beta-3 Adrenergic Receptor Agonism, 10.1016/j.jacc.2011.12.046
  69. Patterson Andrew J., Zhu Weizhong, Chow Amy, Agrawal Rani, Kosek Jon, Xiao Rui Ping, Kobilka Brian, Protecting the myocardium: A role for the β2 adrenergic receptor in the heart : , 10.1097/01.ccm.0000120049.43113.90
  70. Pitcher Julie A., Freedman Neil J., Lefkowitz Robert J., G PROTEIN–COUPLED RECEPTOR KINASES, 10.1146/annurev.biochem.67.1.653
  71. Porta S., Rinner I., Egger G., Rangetiner B., Sadjak A., Enhancement of Adrenaline Plasma-Levels Shortens Adrenaline Half-Life, 10.1055/s-2007-1013513
  72. Rohrer D. K., Desai K. H., Jasper J. R., Stevens M. E., Regula D. P., Barsh G. S., Bernstein D., Kobilka B. K., Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects., 10.1073/pnas.93.14.7375
  73. RONA G, Catecholamine cardiotoxicity, 10.1016/s0022-2828(85)80130-9
  74. Saeed M., Sommer O., Holtz J., Bassenge E., α-Adrenoceptor Blockade by Phentolamine Causes β-Adrenergic Vasodilation by Increased Catecholamine Release Due to Presynaptic α-Blockade : , 10.1097/00005344-198201000-00008
  75. Schwinger Robert H.G., Münch Götz, Bölck Brigit, Karczewski Peter, Krause Ernst-Georg, Erdmann Erland, Reduced Ca2+-Sensitivity of SERCA 2a in Failing Human Myocardium due to Reduced Serin-16 Phospholamban Phoshorylation, 10.1006/jmcc.1998.0897
  76. Skeberdis V. Arvydas, Gendvilieneη Vida, Zablockaiteη Danguoleη, Treinys Rimantas, Macχianskieneη Regina, Bogdelis Andrius, Jurevicχius Jonas, Fischmeister Rodolphe, β3-adrenergic receptor activation increases human atrial tissue contractility and stimulates the L-type Ca2+ current, 10.1172/jci32519
  77. Sorrentino Sajoscha A., Doerries Carola, Manes Costantina, Speer Thimoteus, Dessy Chantal, Lobysheva Irina, Mohmand Wazma, Akbar Razma, Bahlmann Ferdinand, Besler Christian, Schaefer Arnd, Hilfiker-Kleiner Denise, Lüscher Thomas F., Balligand Jean-Luc, Drexler Helmut, Landmesser Ulf, Nebivolol Exerts Beneficial Effects on Endothelial Function, Early Endothelial Progenitor Cells, Myocardial Neovascularization, and Left Ventricular Dysfunction Early After Myocardial Infarction Beyond Conventional β1-Blockade, 10.1016/j.jacc.2010.09.037
  78. Susulic Vedrana S., Frederich Robert C., Lawitts Joel, Tozzo Effie, Kahn Barbara B., Harper Mary-Ellen, Himms-Hagen Jean, Flier Jeffrey S., Lowell Bradford B., Targeted Disruption of the β3-Adrenergic Receptor Gene, 10.1074/jbc.270.49.29483
  79. Swedberg K., Eneroth P., Kjekshus J., Wilhelmsen L., Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group, 10.1161/01.cir.82.5.1730
  80. Tagaya E., Tamaoki J., Takemura H., Isono K., Nagai A., Atypical Adrenoceptor-mediated Relaxation of Canine Pulmonary Artery Through a Cyclic Adenosine Monophosphate–dependent Pathway, 10.1007/pl00007650
  81. Trappanese Danielle M., Liu Yuchuan, McCormick Ryan C., Cannavo Alessandro, Nanayakkara Gayani, Baskharoun Marina M., Jarrett Harish, Woitek Felix J., Tillson D. Michael, Dillon A. Ray, Recchia Fabio A., Balligand Jean-Luc, Houser Steven R., Koch Walter J., Dell’Italia Louis J., Tsai Emily J., Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy, 10.1007/s00395-014-0456-3
  82. Treinys Rimantas, Zablockaitė Danguolė, Gendvilienė Vida, Jurevičius Jonas, Skeberdis V. Arvydas, β3-Adrenergic Regulation of L-Type Ca2+ Current and Force of Contraction in Human Ventricle, 10.1007/s00232-014-9635-2
  83. van Marken Lichtenbelt Wouter D., Vanhommerig Joost W., Smulders Nanda M., Drossaerts Jamie M.A.F.L., Kemerink Gerrit J., Bouvy Nicole D., Schrauwen Patrick, Teule G.J. Jaap, Cold-Activated Brown Adipose Tissue in Healthy Men, 10.1056/nejmoa0808718
  84. Vij Monika, Drake Marcus J., Clinical use of the β3 adrenoceptor agonist mirabegron in patients with overactive bladder syndrome, 10.1177/1756287215591763
  85. Virtanen Kirsi A., Lidell Martin E., Orava Janne, Heglind Mikael, Westergren Rickard, Niemi Tarja, Taittonen Markku, Laine Jukka, Savisto Nina-Johanna, Enerbäck Sven, Nuutila Pirjo, Functional Brown Adipose Tissue in Healthy Adults, 10.1056/nejmoa0808949
  86. Watts Vabren L., Sepulveda Fernando M., Cingolani Oscar H., Ho Alice S., Niu Xiaolin, Kim Rosa, Miller Karen L., Vandegaer Koenraad, Bedja Djahida, Gabrielson Kathleen L., Rameau Gerald, O'Rourke Brian, Kass David A., Barouch Lili A., Anti-hypertrophic and anti-oxidant effect of beta3-adrenergic stimulation in myocytes requires differential neuronal NOS phosphorylation, 10.1016/j.yjmcc.2013.04.025
  87. Xiao RP, Ji X, Lakatta EG (1995) Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol 47:322–329
  88. Zhu W.-Z., Zheng M., Koch W. J., Lefkowitz R. J., Kobilka B. K., Xiao R.-P., Dual modulation of cell survival and cell death by  2-adrenergic signaling in adult mouse cardiac myocytes, 10.1073/pnas.98.4.1607